TY - JOUR T1 - Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK- 8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. JF - Lancet HIV Y1 - 2015 A1 - J K Rockstroh A1 - Nelson, M. A1 - Katlama, C. A1 - et, al VL - 2 SP - e319-327 IS - 8 ER -